Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Manny Ventura, PhD Manny Ventura, PhD Senior Director and Site Head at ChemPartner US Q&A with Manny What is your favorite part of...
In order to stay competitive in the biopharmaceutical industry, companies are increasingly turning to outsourcing as a means of gaining an advantage. With the many competing Contract Development and Manufacturing Organizations (CDMOs) and Contract Research...
The race to first-in-human clinical trials has become more critical than ever for drug developers. The FDA has even developed 4 major tracks to speed up the process and make drugs available to patients as fast as possible: Fast Track: Facilitates drug development and...
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Maria Trance Maria Trance Senior Operations Manager Q&A with Maria What is your favorite part of your role here as a Senior Operations...
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Neha Yevalakar Neha Yevalekar Senior Scientist at ChemPartner Q&A with Neha What is your favorite part of your role here as a Senior...
The combined small and large molecule Contract Development and Manufacturing Organization (CDMO) market was valued at $52.8 billion dollars in 2021 with annual growth rates of 6.5% and 8.6% (respectively) from 2022 to 2030. So, why are more and more biotech and...
Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Dr. Lilly Xu Dr. Lilly Xu SVP and Head of DMPK and Exploratory Toxicology at ChemPartner Q&A with Dr. Xu How long have you been with...
Gileadʹs antiviral drug remdesivir (Veklury, 1) was approved by the FDA on May 1st for emergency use against coronavirus disease-2019 (COVID-19) after just a one-day review. Now the onerous task falls upon Gilead to make enough of the drug to supply doctors and...
Gileadʹs antiviral drug remdesivir has been catapulted to the limelight as the only FDA-approved treatment of coronavirus Covid-19 for emergency use thus far. On April 29, 2020, preliminary clinical trials indicated that the drug has shown some efficacy. While...
On June 16th, 2020, a team at Oxford University announced that their RECOVERY trials had revealed that a daily treatment of 6 mg of dexamethasone (Decadron, 1) lowered the fatality rate of ventilated COVID-19 patients by up to one third! This was a randomized,...